SDSandra Dury

Sandra Dury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Dury has a total of 113 co-authors. Here are the top co-authors by number of shared publications:

  • Gaëtan Deslée

    Service de Pneumologie, INSERM UMRS-1250, CHU de Reims, Reims, France

    15 shared publications
  • François Lebargy

    Service des maladies respiratoires, CHU Reims, CHU Maison Blanche, 45, rue Cognacq-Jay, 51092 Reims, France; EA7509 IRMAIC, université de Reims Champagne-Ardenne, Reims, France

    14 shared publications
  • Jeanne-Marie Perotin

    P3Cell UMR-S1250, Inserm, CHU de Reims, université de Reims Champagne-Ardenne, Reims, France; Inserm, F-CRIN, Clinical Research Initiative in Severe Asthma: A Lever for Innovation, Science (CRISALIS), Toulouse, France

    7 shared publications
  • François Lebargy

    Service des Maladies Respiratoires et Allergiques, Université de Reims Champagne-Ardenne, EA7509 IRMAIC, CHU de Reims, Reims, France

    6 shared publications
  • Bruno Ravoninjatovo

    Service des Maladies Respiratoires et Allergiques, CHU de Reims, Reims, France

    5 shared publications
  • Claire Launois

    Service des Maladies Respiratoires et Allergiques, CHU de Reims, Reims, France

    5 shared publications

Latest Publications

  • Prise en charge sociale des patients adultes suivis pour une mucoviscidose

    by S. Dury, P. Mulette, A. Vivien, H. Yucel-Farcet, E. Longueville, A. Boutahir, B. Ravoninjatovo, A. Deforge, M. Griffon, F. Deschamps, et al.

  • Open Access

    Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis

    by Lucie Charon, Claire Launois, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Pauline Mulette, Julien Ancel, Thomas Guillard, Anaëlle Muggeo, Valérian Dormoy, Muriel Griffon, et al.

    Background: Cough and sputum are major symptoms in cystic fibrosis (CF) that contribute to the impairment of quality of life. Methods: This prospective single centre cross-sectional pilot study aimed to evaluate the results of a self-administered questionnaire assessing cough and sputum symptoms (2 domains), and their impact (2 domains) on daily activities in the previous week, named the Cough and Sputum Assessment Questionnaire (CASA-Q) in CF adult patients at stable state, and to analyse associations with clinical, functional, microbiological, radiological data, and two quality of life scales: the Cystic Fibrosis Questionnaire Revised (CFQ-R) and the Saint George Respiratory Questionnaire (SGRQ). Results: Forty-eight patients were included in this analysis (69% men; median age of 27.8 ± 8.1 years; median body mass index of 21.8 + 3.3 kg/m²; mean FEV1 of 64 ± 30% of the predicted value). The mean values of the CASA-Q domains were 58 ± 23 for cough symptoms, 77 ± 24 for cough impact, 62 ± 25 for sputum symptoms and 84 ± 21 for sputum impact. Impairment in CASA-Q cough and sputum domains was associated with dyspnea mMRC scale (p < 0.005 for all 4 domains of CASA-Q) and exacerbations in the previous year (p < 0.05 for CASA-Q symptoms domains). We also found correlations between all domains of the CASA-Q and quality of life questionnaires including SGRQ (p < 0.001) and to a lesser extend CFQ-R. We identified a clinical phenotype (female gender, ΔF508 heterozygous mutation, dyspnea mMRC scale) associated with an impairment of CASA-Q score and quality of life using a 2-step cluster analysis. Conclusions: CASA-Q allows the assessment of cough and sputum in CF adult patients and is associated with quality of life impairment. This simple easy-to-use tool could be used in routine clinical practice and in clinical studies to assess cough and sputum in CF patients. Trial Registration: The study was registered on ClinicalTrials.gov (NCT02924818, first posted on 5th October 2016).


  • Open Access

    Current cough and sputum assessed by the Cough And Sputum Assessment-Questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis

    by Lucie Charon, Claire Launois, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Pauline Mulette, Julien Ancel, Thomas Guillard, Anaëlle Muggeo, Valérian Dormoy, Muriel Griffon, et al.

    Background Cough and sputum are major symptoms in cystic fibrosis (CF) that contribute to the impairment of quality of life.Methods This prospective monocentric cross-sectional pilot study aimed to describe the results of the Cough and Sputum Assessment Questionnaire (CASA-Q) in CF adult patients at stable state, and to analyse associations with clinical, functional, microbiological, radiological data, and two quality of life scales: the Cystic Fibrosis Questionnaire Revised (CFQ-R) and the Saint George Respiratory Questionnaire (SGRQ).Results Forty-eight patients were included in this analysis (69% men; median age of 27.8 years; median body mass index of 21.8 kg/m²; mean FEV1 of 64% of the predicted value). The mean values of the CASA-Q domains were 58 for cough symptoms, 77 for cough impact, 62 for sputum symptoms and 84 for sputum impact. Impairment in CASA-Q cough and sputum domains was associated with dyspnea mMRC scale and exacerbations in the previous year. We also found correlations between all domains of the CASA-Q and quality of life questionnaires including SGRQ and to a lesser extend CFQ-R. We identified a clinical phenotype (female gender, ΔF508 heterozygous mutation, dyspnea mMRC scale) associated with an impairment of CASA-Q score and quality of life.Conclusions CASA-Q allows the assessment of cough and sputum in CF adult patients and is associated with quality of life impairment. This simple easy-to-use tool could be used in routine clinical practice and in clinical studies to assess cough and sputum in CF patients.Trial Registration The study was registered on ClinicalTrials.gov (NCT02924818) on 5th October 2016.

  • Open Access

    Clinical relevance of low bone density in cystic fibrosis adult patients: A pilot study

    by Sandra Dury, Julien Ancel, Bruno Ravoninjatovo, Isabelle Lambrecht, Jeanne-Marie Perotin, Pauline Mulette, François Lebargy, Jean-Hugues Salmon, Gaëtan Deslée, Claire Launois

    Survival improvement in cystic fibrosis (CF) is associated with more frequent long-term complications, including CF related bone disease (CFBD). Impact of CFBD on global health outcome remains poorly described. We aimed to assess the relationship between low bone mineral density (BMD) and spinal pain, disability, and quality of life in CF adult patients. This monocentric cross-sectional study with prospective data collection was conducted from November 2016 to December 2019 in the Department of Respiratory Diseases at the University Hospital of Reims (NCT02924818). BMD was assessed by X-ray absorptiometry (DXA). Disability was assessed by the Health Assessment Questionnaire (HAQ). Quality of life was assessed by both the St George’s Respiratory Questionnaire and the Cystic Fibrosis Questionnaire for teenagers and adults (CFQ 14+). Forty patients were analyzed, 68% of men, with a median age of 25 years, a median body mass index of 21 kg/m² and a median FEV1% of 54%. Nine patients (23%) had spinal pain. Ten patients (25%) had a low BMD. Compared with patients with normal BMD, patients with low BMD had a significantly lower BMI (22 vs 19 kg/m²; P = .006) and less vitamin D supplementation (33% vs 0%; P = .035). Low BMD was not associated with spinal pain, disability and quality of life. Low BMD is frequent in CF, affecting 1-quarter of adult patients. No significant association was found between low BMD and spinal pain, disability or quality of life.


  • Open Access

    Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors

    by Julien Ancel, Claire Launois, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Pauline Mulette, Jean Hagenburg, Julie Malet, Muriel Griffon, Sophie Carré, François Lebargy, et al.

    Background: Cystic Fibrosis (CF) adult patients experience daily physical symptoms and disabilities that may impact their quality of life and mental health. Methods: This prospective study aimed to evaluate the relative contribution of the familial, occupational, and social environment, besides that of the main physical and mental health factors, to the quality of life of CF adult patients using the Cystic Fibrosis Questionnaire-Revised (CFQ-R) in a multivariate model. Results: Fifty patients were analyzed (70% of men; median age of 25 years; median body mass index of 21 kg/m²; median FEV1 of 57%). Anxiety and depression scores were negatively associated with 9 of the 12 CFQ-R domains. When controlling for anxiety and depression, FEV1% and BMI were significant positive predictors of several domains of the CFQ-R. All the familial, occupational, and social components analyzed but one (professional training) were predictors of at least one domain of the CFQ-R. Conclusion: Anxiety and depression explained a greater proportion of the variance than physical variables (age, sex, BMI, FEV1%, and exacerbation in the last year) in CF HRQoL. Many familial, occupational, and social components were also specifically and independently predictors of some HRQoL domains. Their screening might help identifying CF patients eligible for specific interventions, focusing on the impaired QoL dimensions.


  • Open Access

    Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients

    by Axelle Schmoll, Claire Launois, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Muriel Griffon, Sophie Carré, Pauline Mulette, Julien Ancel, Jean Hagenburg, François Lebargy, et al.

    Background: With the improvement of cystic fibrosis (CF) patient survival, the prevalence of long-term complications increased, among them rheumatologic disorders.Methods: The aim of this prospective study was to evaluate the prevalence of spinal and joint pain, and their impact on disability, anxiety, depression, and quality of life in CF adult patients.Results: Forty-seven patients were analyzed, 72% of men, mean aged 28 years, with a mean body mass index of 22 kg/m2 and a mean FEV1% of 63%. Twenty-two patients (47%) described rheumatologic pain either spinal (n = 15, 32%) and/or joint pain (n = 14, 30%). Patients with spinal and/or joint pain were shorter (p = 0.023), more frequently colonized with Staphylococcus aureus (p < 0.008), had more frequent ΔF508 homozygous mutations (p = 0.014), and a trend for more impairment of the 6-min walking distance (p = 0.050). The presence of rheumatologic pain tended to be associated with disability according to the Health Assessment Questionnaire (HAQ) and anxiety. Compared with patients with no pain patients with both spinal and joint pain exhibited a more pronounced impact on the St George's Respiratory Questionnaire (SGRQ).Conclusion: Rheumatologic pain is frequent in CF adult patients, and may affect daily living, anxiety and quality of life. Systematic assessment of rheumatologic pain should be included in the management of CF patients.


  • Open Access

    Identifying specific needs in adult cystic fibrosis patients: a pilot study using a custom questionnaire

    by Sandra Dury, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Catherine Llerena, Julien Ancel, Pauline Mulette, Muriel Griffon, Sophie Carré, Amélie Perrin, François Lebargy, et al.

    Adult patients with cystic fibrosis (CF) experience daily physical symptoms and disabilities that can be challenging to address for health care teams. We sought to identify the most frequent topics that CF adults need to discuss with health care teams using a custom questionnaire including 62 items. Fifty patients were included, 70% men, mean age 27.6 years, with a mean body mass index of 21.8 kg/m2. Mean FEV1% was 64% of predicted value. Forty-two percent of patients selected at least one topic. The most frequently selected topics were fatigue (20%), professional or scholar worries (18%), procreation (16%), physical activities (16%) and evolution of CF disease (16%). Women were more frequently concerned about fatigue, procreation and profession/school. Using a custom questionnaire, we identified that CF adults express various unmet needs that extend beyond usual respiratory and nutritional concerns or treatment adherence. The interest of this questionnaire by health care team for improving therapeutic management of CF patients remains to be validated. Trial registration: The study was registered on ClinicalTrials.gov (NCT02924818) on 5th October 2016.


  • Open Access

    An unusual cause of calcified pulmonary opacity: A metastasis of a benign giant cell tumour of bone

    by S. Dury, A. Malihy, M. Mahfoud, C. Launois, J.M. Perotin, G. Deslée, F. Lebargy


  • Open Access

    Nuclear protein in testis carcinoma of the mediastinum: a case report

    by Gonçalo Boleto, Jeanne-Marie Perotin, Claire Launois, Emmanuelle Uro-Coste, Philippe Birembaut, Sandra Dury, Hervé Vallerand, François Lebargy, Gaëtan Deslée, Juliette Vella-Boucaud

    Nuclear protein in testis carcinoma is a rare and very aggressive undifferentiated cancer which characteristically arises in the midline of the head, neck, and mediastinum. We describe the case of a 46-year-old white woman admitted for superior vena cava syndrome revealing a mediastinal tumor. Pathological examination of specimens obtained by mediastinoscopy revealed an undifferentiated tumor with solid growth and positive immunoreactivity for p40 and negative immunoreactivity for cytokeratin markers. Immunohistochemical staining was positive for nuclear protein in testis, allowing the diagnosis of nuclear protein in testis midline carcinoma of the mediastinum. We present a rare case of mediastinal nuclear protein in testis carcinoma with diagnosis based on nuclear protein in testis protein positivity and atypical immunohistochemical features including p40 positivity and anti-cytokeratin negativity. Physicians must remain aware of the possibility of nuclear protein in testis carcinoma especially in young patients with thoracic symptoms and suspicion of neoplasm.


  • Hypoventilation alvéolaire sévère révélant un shrinking lung syndrome lupique

    by Y. Ammar, C. Launois, J.-M. Perotin, S. Dury, A. Servettaz, D. Perdu, H. Vallerand, J. Nardi, C. Boulagnon-Rombi, M. Pluot, et al.